U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07026526) titled 'Human Milk Oligosaccharides' Impact on Maturation of the Gut Microbiota' on June 10.
Brief Summary: Human milk oligosaccharides (HMOs) are the third largest component of human milk after fat and milk sugar (lactose). HMOs play an important role in selecting the gut microbiota (GM) in newborn breastfed infants. However, the mechanisms underpinning the maturation process that the gut microbiota undergoes during the transition from a breast milk to a solid food diet (weaning) and the impact of HMOs on this transition remain unknown.
The aim of the present study:
* Evaluate the contribution of HMOs to the maturation of the GM during w...